Crosslinking (CXL) provides a stiffer cornea. A significant change in endothelial cell density after CXL has not been reported. There is a synergistic effect in the combination of ICRS and CXL ...
The study also found no significant changes in intraocular pressure or anterior chamber depth, with the mean change in corneal endothelial cell density at six months being -280.7 cells/mm².
One-year data of high-fluence accelerated epithelium-off corneal cross-linking for keratoconus showed efficacy comparable to ...
A regenerative treatment is needed to reverse age-related loss of corneal endothelial cells (CEC). A significant opportunity awaits the company that delivers an effective treatment. Corneal ...
AURN001 is a combination cell therapy product candidate comprised of allogeneic human corneal endothelial cells (neltependocel) and a rho kinase inhibitor (Y-27632). This investigational product ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果